Further testing of morphometric grading in TA,1 urothelial carcinomas of the urinary bladder and the additional value of p53 immunoquantitation

Analytical and Quantitative Cytology and Histology

Volumn 24, Issue 2, 2002, Pages 114-120

  Bol, Marco G W ^a   Baak, Jan P A ^a   Janssen, Emiel A M ^a   Breeuwsma, Nelly G ^a   De Bruin, Peter C ^a  

^a SIR Hospital   (Norway)

Author keywords

Bladder cancer; Ki 67; MAI; MNA 10; Morphometry; p53 protein; Urothelium

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; MODEL; MORPHOMETRICS; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PRIORITY JOURNAL; QUANTITATIVE HISTOCHEMISTRY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CELL NUCLEUS; DISCRIMINANT ANALYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOMETRY; KI-67 ANTIGEN; MIDDLE AGED; MITOTIC INDEX; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

MYCOBACTERIUM AVIUM-INTRACELLULARE;

EID: 0036234431     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. A,1 transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features
2. Grading of superficial bladder cancer by quantitative mitotic frequency analysis
3. The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma
4. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas
5. Stage progression in Ta papillary urothelial tumors: Relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy
6. The reliability of staging and grading of bladder tumours: Impact of misinformation on the pathologist's diagnosis
7. Analysis of the performance of pathologists in the grading of bladder tumors
8. Morphometric grading of bladder tumours in comparison with histologic grading by pathologists
9. The reliability and reproducibility of the different classifications of bladder cancer
10. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma
11. p53 function and dysfunction
12. Abnormal centrosome amplification in the absence of p53
13. Predictive value of cell cycle markers p53, mdm2, p21 and ki-67 in superficial bladder tumor recurrence
14. The natural history of bladder cancer